https://doi.org/10.4081/aiua.2021.1.35

Maternal hydronephrosis in pregnant women without ureteral stones and characteristics of symptomatic cases who need treatment: A single-center prospective study with 1026 pregnant women

Vol. 93 No. 1 (2021)
Submitted: August 27, 2020
Accepted: October 21, 2020
Published: March 18, 2021
Hydronephrosis, Pregnancy, Maternal, Symptomatic, Treatment
Abstract Views: 3000
PDF: 5313
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Zeki Bayraktar
zbayraktar@medipol.edu.tr
Department of Urology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Şerife Tuğba Kahraman
Department of Obstetrics and Gynecology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Elif Seçkin Alaç
Department of Obstetrics and Gynecology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
İrem Yengel
Department of Obstetrics and Gynecology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Deniz Sarıkaya Kalkan
Department of Obstetrics and Gynecology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.

Purpose: The aim of this study is to determine the proportion of maternal hydronephrosis and symptomatic cases requiring treatment in pregnant women without ureteral stones and the characteristics of these cases.
Materials and methods: Between February 2018 and April 2019, all pregnant women followed for pregnancy in obstetrics and outpatient policlinic were evaluated prospectively. Maternal hydronephrosis rate, degree of hydronephrosis and side, symptomatic hydronephrosis rate, maximum renal anteroposterior diameter of renal pelvis and visual analogue scale were detected. Symptomatic patients were treated conservatively or surgically. Findings in both treatment groups were analyzed by t-test or Chi-squared test. Pearson or Spermean’s tests were used for correlation analyzes.
Results: A total of 1026 pregnant women aged 18-45 (27.7 ± 5.2 years) were followed prospectively. The rate of maternal hydronephrosis was 28.7% and the rate of symptomatic hydronephrosis was 4.7%. Of the patients with symptomatic hydronephrosis, 73.4% (3.5% of total) were treated conservatively and 26.5% (1.3% of total) were treated surgically. There was a positive correlation between hydronephrosis and gestational week (p < 0.001), visual analogue scale (p < 0.001) and hematuria (p < 0.05). There was a negative correlation between hydronephrosis and maternal age (p < 0.05) and number of pregnancies (p < 0,001). The anteroposterior diameter of renal pelvis (p < 0.001), visual analogue scale (p < 0.05) and fetal body weight values (p < 0.05) on the right side were higher in the surgical treatment group than the conservative group.
Conclusions: The majority of cases with maternal hydronephrosis in pregnant women without ureteral stones are asymptomatic. Most symptomatic cases can also be treated conservatively. In cases requiring surgical treatment (1.3%), fetal body weight, visual analogue scale and anteroposterior renal pelvis diameter are higher.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Ercil H, Arslan B, Ortoglu F et al. Conservative/surgical treatment predictors of maternal hydronephrosis: results of a single-center retrospective non-randomized non-controlled observational study. Int Urol Nephrol. 2017:49:1347-52 DOI: https://doi.org/10.1007/s11255-017-1619-6
Fainaru O, Amnog B, Gamzu R, Lessing JB, Kupferminc M. The management of symptomatic hydronephrosis in pregnancy. Br J Obstet Gynecol. 2002:109:1385-87 DOI: https://doi.org/10.1046/j.1471-0528.2002.01545.x
Goldfarb RA, Neerhurt GJ, Lederer E. Management of acute hydronephrosis of pregnancy by ureteral stenting: risk of stone formation. J Urol. 1989:141:921-22 DOI: https://doi.org/10.1016/S0022-5347(17)41053-6
Wadasinghe SU, Metcalf L, Metcalf P, Perry. Maternal Physiologic Renal Pelvis Dilatation in Pregnancy: Sonographic Reference Data. J Ultrasound Med. 2016;35:2659-2664 DOI: https://doi.org/10.7863/ultra.15.12036
Tsai YL, Seow KM, Yieh CH et al. Comparative study of conservative and surgical management for symptomatic moderate and severe hydronephrosis in pregnancy: a prospective randomized study. Acta Obstet Gynecol Scand. 2007:86:1047-50 DOI: https://doi.org/10.1080/00016340701416713
Docimo SG, Dewolf WC. High failure rate of indwelling ureteral stents in patients with extrinsic obstruction: experience at 2 institutions. J Urol. 1989:142:277-79 DOI: https://doi.org/10.1016/S0022-5347(17)38729-3
Jarrard DJ, Gerber GS, Lyon ES. Management of acute ureteral obstruction in pregnancy utilizing ultrasound-guided placement of ureteral stents. J Urol.1993:42:263-68
Zwergel T, Lindenmeir T, Wullich B. Management of acute hydronephrosis in pregnancy by ureteral stenting. Eur Urol. 1996:29:292-97 DOI: https://doi.org/10.1159/000473763
Puskar D, Balagovic I, Filipovic A et al. Symptomatic physiologic hydronephrosis in pregnancy: incidence, complications and treatment. Eur Urol. 2001:39:260-63 DOI: https://doi.org/10.1159/000052449
Jarrard DJ, Gerber GS, Lyon ES. Management of acute ureteral obstruction in pregnancy utilizing ultrasound-guided placement of ureteral stents. J Urol 1993:42:263-67 DOI: https://doi.org/10.1016/0090-4295(93)90614-G
Hellawell GO, Cowan NC, Holt SJ, Mutch SJ. A radiation perspective for treating loin pain in pregnancy by doublepigtail stents. BJU Int. 2002:90:801-808 DOI: https://doi.org/10.1046/j.1464-410X.2002.03061.x
Ringel A, Richter S, Shalev M, Nissenkorn I. Late complications of ureteral stents. Eur Urol. 2000:38:41-4 DOI: https://doi.org/10.1159/000020250
Choi CI, Yu YD, Park DS. Ureteral stent insertion in the management of renal colic during pregnancy. Chonnam Med J 2016:52:123–27 DOI: https://doi.org/10.4068/cmj.2016.52.2.123
Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol 2014:210:219e1–6 DOI: https://doi.org/10.1016/j.ajog.2013.10.006
Cietak KA, Newton JR. Serial qualitative maternal nephrosonography in pregnancy. Br Br J Radiol. 1985:58:399-404 DOI: https://doi.org/10.1259/0007-1285-58-689-399
Cietak KA, Newton JR. Serial quantitative maternal nephrosonography in pregnancy. J Radiol. 1985:58:405-13 DOI: https://doi.org/10.1259/0007-1285-58-689-405
Di Salvo DN. Sonographic imaging of maternal complications of pregnancy. J Ultrasound Med 2003:22:69–89
Rasmussen PE, Nielsen FR. Hydronephrosis during pregnancy: a literature survey. Eur J Obstet Gynecol Reprod Biol 1988:27:249–59 DOI: https://doi.org/10.1016/0028-2243(88)90130-X
Sadan O, Berar M, Sagiv R et al. Ureteric stent in severe hydronephrosis of pregnancy. Eur J Obstet Gynecol Reprod Biol. 1998:56:79-81 DOI: https://doi.org/10.1016/0028-2243(94)90260-7
Clayton JD, Roberts JA. The effect of progesterone on ureteral physiology in a primate model. J Urol 1972:107:945–48 DOI: https://doi.org/10.1016/S0022-5347(17)61177-7
Dell'Atti L. Our ultrasonographic experience in the management of symptomatic hydronephrosis during pregnancy. J Ultrasound. 2014:21;19:1-5 DOI: https://doi.org/10.1007/s40477-014-0109-2
Oto A, Ernst RD, Ghulmiyyah LM et al. MR imaging in the triage of pregnant patients with acute abdominal and pelvic pain. Abdom Imaging 2009:34:243–50 DOI: https://doi.org/10.1007/s00261-008-9381-y
Di Salvo DN. Sonographic imaging of maternal complications of pregnancy. J Ultrasound Med 2003:22:69–89 DOI: https://doi.org/10.7863/jum.2003.22.1.69
Elgamasy A, Elsherif A. Use of Doppler ultrasonography and rigid ureteroscopy for managing symptomatic ureteric stones during pregnancy. BJU International 2009:106:262–66 DOI: https://doi.org/10.1111/j.1464-410X.2009.08950.x
Faúndes A, Brícola-Filho M, Pinto e Silva JL. Dilatation of the urinary tract during pregnancy: proposal of a curve of maximal caliceal diameter by gestational age. Am J Obstet Gynecol 1998:178:1082–86 DOI: https://doi.org/10.1016/S0002-9378(98)70552-6
Kajbafzadeh AM, Keihani S, Kameli SM, Hojjat A. Maternal Urinary Carbohydrate Antigen 19-9 as a Novel Biomarker for Evaluating FetalHydronephrosis: A Pilot Study. Urology. 2017:101:90-93 DOI: https://doi.org/10.1016/j.urology.2016.10.038
Farr A, Ott J, Kueronya V et al. The association between maternal hydronephrosis and acute flank pain during pregnancy: a prospective pilot-study. J Matern Fetal Neonatal Med. 2017:30:2417-21 DOI: https://doi.org/10.1080/14767058.2016.1252328
Naber KG, Bergman B, Bishop MC et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection(UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 2001:40:576–88 DOI: https://doi.org/10.1159/000049840
Watson WJ, Brost BC. Maternal hydronephrosis in pregnancy: poor association with symptoms of flank pain. Am J Perinatol. 2006:23:463-66 DOI: https://doi.org/10.1055/s-2006-954820

How to Cite

Bayraktar, Z., Kahraman, Şerife T., Alaç, E. S., Yengel, İrem, & Sarıkaya Kalkan, D. (2021). Maternal hydronephrosis in pregnant women without ureteral stones and characteristics of symptomatic cases who need treatment: A single-center prospective study with 1026 pregnant women. Archivio Italiano Di Urologia E Andrologia, 93(1), 35–41. https://doi.org/10.4081/aiua.2021.1.35

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.